Clin2
NCT07262008Possibly a fitNot yet recruiting

Laughing gas for depression: a mood improvement trial

Major Depressive DisorderTreatment Resistant Depression

Part of Mental health clinical trials.

This study tests if laughing gas (nitrous oxide) can safely improve mood in adults with depression who haven't gotten better after trying two antidepressant medicines. It may offer a new option for treatment-resistant depression.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
120 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old
  • You have been diagnosed with major depression by a doctor
  • Your current depression is moderate to severe, with a score above 21 on a depression rating scale
  • You have tried at least two different antidepressants for your current episode but they didn't work well enough
  • You are not pregnant or breastfeeding and, if you could become pregnant, you agree to use effective birth control

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03736538Enrolling by invitation· Phase 1
Nitrous oxide for suicidal thoughts in depression

This Phase 1 study tests whether breathing nitrous oxide can safely reduce suicidal thoughts in adults with major depression. It may help people whose depression is causing moderate to severe suicidal thinking, by studying a fast-acting treatment approach.

St Louis, Missouri
NCT06410599Recruiting· Phase 2
Medication boost for tough-to-treat chronic depression

This trial tests a new medication added to your current treatment for chronic depression that hasn't gotten better with at least two antidepressants and 12 therapy sessions. It might help when standard treatments aren't enough.

Tübingen, Baden-Würtemberg
NCT05327699Recruiting· Early Phase 1
Ketamine study for depression with reduced pleasure

This early-phase study tests whether ketamine can help people with major depression who have trouble feeling pleasure. It also studies how the brain may change in response to stress, to better understand who might respond to treatment.

Atlanta, Georgia
NCT05973851Recruiting· Phase 3
Six-week medicine boost for depression after first treatment failure

This study tests a more intensive antidepressant medicine approach for people whose first tried treatment didn’t work well enough. It compares the intensified treatment with usual care, aiming to improve depression symptoms and daily functioning.

Innsbruck
NCT05136755Recruiting· Phase 2
NMDA treatment for depression that did not improve

This trial studies an NMDA-based treatment for people with major depressive disorder who did not respond to at least one antidepressant. It may help by changing brain signaling linked to depression symptoms.

Taichung
NCT06168175Not yet recruiting· Phase 2
Lactate for recent major depression

This trial tests if adding lactate (a natural body chemical) to your regular treatment can help people recently hospitalized for major depression feel better faster. It involves having an IV line for 5 days.

Hear when a new Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.